Search / Trial NCT00000398

Behavioral Treatment of Fibromyalgia

Launched by OHIO UNIVERSITY · Nov 3, 1999

Apply for Trial

Trial Information

Current as of September 08, 2024

Completed

Keywords

Fibromyalgia Pain Coping Skills Training Physical Exercise Training Combined Coping Skills Training And Exercise Training

Description

Fibromyalgia (FM) is characterized by diffuse musculoskeletal pain, discrete tender points at typical soft-tissue sites, fatigue, stiffness, and sleep problems. Of these symptoms, pain is often the primary concern of FM patients and their physicians. Traditional medical approaches to managing FM have limitations (side effects) and have not been effective in managing pain. Given these limitations, treatments that involve nonpharmacologic interventions may represent a valuable addition to patient care. This study will evaluate the effects of two of the most promising nonpharmacologic interven...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Complaints of pain persisting for 6 months
  • * Meet diagnostic criteria for fibromyalgia (American College of Rheumatology criteria)
  • Exclusion Criteria:
  • * A significant adverse medical condition that would expose the individual to increased risk of an adverse experience during the course of the trial (e.g. a recent (\<6 months) myocardial infarction)
  • * An abnormal cardiac response to exercise
  • * Other significant rheumatic disease
  • * Receiving or applying for disability or compensation benefits because of fibromyalgia

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Columbus, Ohio, United States

Athens, Ohio, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0